Health Canada To Investigate Relenza
Health Canada opted to take the additional safety step even though the Canadian federal agency updated the labeling for GlaxoSmithKline’s Relenza last month, News Inferno reported on Wednesday.
The U.S. Food and Drug Administration expressed concern in November about the potential side effects of numerous anti-flu drugs.
A majority of the FDA’s Pediatric Advisory Committee...
To view the full article, register now.